tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
US Market
XVIPF
Xvivo Perfusion AB
RESEARCH TOOLSreports

Xvivo Perfusion AB (XVIPF) Stock Forecast & Price Target

Compare
10 Followers
See the Price Targets and Ratings of:

XVIPF Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Xvivo
Perfusion AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

XVIPF Stock 12 Month Forecast

There Are No Analyst Ratings for XVIPF In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

XVIPF Financial Forecast

XVIPF Earnings Forecast

Next quarter’s earnings estimate for XVIPF is $0.07 with a range of $0.00 to $0.13. The previous quarter’s EPS was $0.12. XVIPF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year XVIPF has Performed in-line its overall industry.
Next quarter’s earnings estimate for XVIPF is $0.07 with a range of $0.00 to $0.13. The previous quarter’s EPS was $0.12. XVIPF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year XVIPF has Performed in-line its overall industry.

XVIPF Sales Forecast

Next quarter’s sales forecast for XVIPF is $26.00M with a range of $24.04M to $27.36M. The previous quarter’s sales results were $25.40M. XVIPF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.06% of the time in the same period. In the last calendar year XVIPF has Performed in-line its overall industry.
Next quarter’s sales forecast for XVIPF is $26.00M with a range of $24.04M to $27.36M. The previous quarter’s sales results were $25.40M. XVIPF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.06% of the time in the same period. In the last calendar year XVIPF has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Danske Bank Analyst forecast on XVIPF
Erik Cassel
Danske Bank
Danske Bank
$63.39→$36.79
Sell
83.85%
Upside
Downgraded
03/25/25
Xvivo Perfusion downgraded to Sell from Buy at Danske BankXvivo Perfusion downgraded to Sell from Buy at Danske Bank
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Danske Bank Analyst forecast on XVIPF
Erik Cassel
Danske Bank
Danske Bank
$63.39→$36.79
Sell
83.85%
Upside
Downgraded
03/25/25
Xvivo Perfusion downgraded to Sell from Buy at Danske BankXvivo Perfusion downgraded to Sell from Buy at Danske Bank
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

XVIPF Analyst Recommendation Trends

Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
0
1
1
1
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
1
1
1
0
In the current month, XVIPF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. XVIPF average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

XVIPF Stock Forecast FAQ

What is XVIPF’s average 12-month price target, according to analysts?
Currently, no data Available
What is XVIPF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for XVIPF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is XVIPF a Buy, Sell or Hold?
      Currently, no data Available
      What is Xvivo Perfusion AB’s price target?
      Currently, no data Available
      What do analysts say about Xvivo Perfusion AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of XVIPF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.